Neuropsychological Dysfunction Due to Liver Disease

  • Ralph E. Tarter
  • Kathleen L. Edwards
  • David H. Van Thiel
Part of the Critical Issues in Neuropsychology book series (CINP)

Abstract

Among all organs, the liver ranks first in both size and the variety of its functional accomplishments. Located between the intestine and systemic circulation, the liver is, in effect, both a filter and a metabolic factory. Through mechanisms regulated by the level of available energy substrate and the two hormones, insulin and glucagon, the liver is the organ that is responsible for determining whether ingested and absorbed nutrients in the form of chemical energy are to be either utilized immediately or to be stored for later use. The liver is also the primary site for the activation, storage, and release of several vitamins. It is additionally a major site of protein synthesis, glycogen synthesis and storage, and is the primary regulator of the plasma level of cholesterol and other fats. An additional important function performed by hepatocytes is the manufacture of bile, a unique biologic detergent containing, among many other components, bile salts and cholesterol. Thus the liver plays an integral role in maintaining the nutritional and metabolic well-being of the organism.

Keywords

Liver Disease Hepatic Encephalopathy Primary Biliary Cirrhosis Hepatic Coma Portacaval Shunt 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acker, W., Majumdar, S., Shaw, G., and Thomson, A. (1982). The relationship between brain and liver damage in chronic alcoholic patients. Journal of Neurology, Neurosurgery and Psychiatry, 45, 984–987.CrossRefGoogle Scholar
  2. Adams, R., and Foley, J. (1953). The neurological disorder associated with liver disease. In H. Merritt and C. Have (Eds.), Metabolic and toxic diseases of the nervous system (pp. 198–237 ). Baltimore: Williams and Wilkins.Google Scholar
  3. Atkinson, M., and Goligher, J. (1960). Recurrent hepatic coma treated by colectomy and rheorectal anastomosis. Lancet, 1, 461–464.CrossRefGoogle Scholar
  4. Bernthal, P., Hays, A., Tarter, R., Lecky, J., Hedgedus, A., and Van Thiel, D. (1987). Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to psychometric indices of encephalopathy. Hepatology, 7, 107–114.PubMedCrossRefGoogle Scholar
  5. Berry, J., Owen, E., Flanagan, J., and Tyor, M. (1960). The effect of acute hyperventilation on the blood ammonia concentration of patients with liver disease. Journal of Laboratory and Clinical Medicine, 55, 849–854.PubMedGoogle Scholar
  6. Bickford, R., and Butt, H. (1955). Hepatic coma: The EEG pattern. Journal of Clinical Investigation, 34, 790–799.PubMedCrossRefGoogle Scholar
  7. Chen, T., and Chen, P. (1977). Essential hepatology. Boston: Butterworth.Google Scholar
  8. Conn, H., and Lieberthal, M. (1979). The hepatic coma syndrome and lactulose. Baltimore: Williams and Wilkins.Google Scholar
  9. Conn, H., Leevy, C., Vahcevic, Z., Rodgers, J., Maddrey, W., Seeff, L., and Levy, L. (1977). Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology, 72, 573–583.PubMedGoogle Scholar
  10. Davidson, P., Willoughby, R., O’Tuama, L., and Swisher, C. (1978). Neurological and intellectual sequelae of Reye’s Syndrome. American Journal of Mental Deficiency, 82, 535–541.PubMedGoogle Scholar
  11. Dudrick, S., Mackie, J., and Serlin, O. (1968). Surgical exclusion of the colon for chronic hepatic encephalopathy. American Journal of Surgery, 115, 57–62.PubMedCrossRefGoogle Scholar
  12. Elsass, P., Lund, Y., and Ranek, L. (1978). Encephalopathy in patients with cirrhosis of the liver. A Neuropsychological study. Scandinavian Journal of Gastroenterology, 13, 241–247.PubMedCrossRefGoogle Scholar
  13. Fung, W., and Khoo, O. (1971). Lactulose in the treatment of acute and chronic hepatic encephalopathy. Singapore Medical Journal, 12, 176–180.PubMedGoogle Scholar
  14. Galambos, J. (1979). Cirrhosis: Epidemiology. In L. Smith (Ed.), Major problems in internal medicine (pp. 261–276 ). Philadelphia: W. B. Saunders.Google Scholar
  15. Geffray, Y., Segrestin, M., and Geffray, P. (1970). Interest du lactulose dans la traitement de l’encephalopathic portocave chronique-a propos de 20 observations. Therapeuteque, 46, 897–901.Google Scholar
  16. Germain, L., Frezinos, J., Louis, A., and Ribet, A. (1973). Effect of lactulose on post-shunt hepatic encephalopathy: A controlled trial. Archive of Applied Digestive Diseases (French), 62, 293–301.Google Scholar
  17. Gilberstadt, S., Gilberstadt, H., Zieve, L., Buegel, B., Collier, R., and McClain, C. (1980). Psychomotor performance deficits in cirrhotic patients without overt encephalopathy. Archives of Internal Medicine, 140, 519–521.PubMedCrossRefGoogle Scholar
  18. Gunderson, H., and Amidsen, A. (1969). The electrophoretic pattern of alkaline phosphatase in schizophrenic females under long-term treatment with neuroleptic drugs and in young and old healthy women. Scandinavian Journal of Clinical and Laboratory Investigation, 24, 173–177.CrossRefGoogle Scholar
  19. Havens, L., and Child, C. (1955). Recurrent psychosis associated with liver disease and elevated blood ammonia. New England Journal of Medicine, 252, 756–759.PubMedCrossRefGoogle Scholar
  20. Hegedus, A., Tarter, R., Van Thiel, D., Schade, R., Gavaler, J., and Starzl, T. (1984). Neuropsychiatric characteristics associated with primary biliary cirrhosis. The International Journal of Psychiatry in Medicine, 14, 303–313.CrossRefGoogle Scholar
  21. James, I., MacDonald, L., and Xanalatos, C. (1974). Effect of ammonium salts on brain metabolism. Journal of Neurology, Neurosurgery and Psychiatry, 37, 948–953.CrossRefGoogle Scholar
  22. Jefferson, J., and Marshall, J. (1981). Neuropsychiatric features of medical disorders. New York: Plenum Press.CrossRefGoogle Scholar
  23. Jervis, G. (1979). Encephalopathy in infantile hepatic cirrhosis. Acta Neuropathologica, 48, 273–275.CrossRefGoogle Scholar
  24. Kardel, T., and Stigsby, B. (1975). Period-amplitude analysis of the electroencephalogram correlated with liver function in patients with cirrhosis of the liver. Electroencephalography and Clinical Neurophysiology, 38, 605–609.PubMedCrossRefGoogle Scholar
  25. Laidlow, J., Read, A., and Sherlock, S. (1961). Morphine tolerance in hepatic cirrhosis. Gastroenterology, 40, 389–396.Google Scholar
  26. Lee, K., Moller, L., Hardt, F., Haubek, A., and Jensen, E. (1979). Alcohol-induced brain damage and liver damage in young males. Lancet, 2, 759–761.PubMedCrossRefGoogle Scholar
  27. Leevy, C. (1974). Exploring the brain-liver relationship. Modern Medicine, 42, 17–22.Google Scholar
  28. Lieber, C., and Leo, M. (1982). Alcohol and the liver. In C. Lieber (Ed.), Medical disorders of alcoholism: Pathogenesis and treatment (pp. 219–312 ). Philadelphia: W. B. Saunders.Google Scholar
  29. Ma, M., McLeod, J., and Blackburn, C. (1969). Long-term treatment of portal-systemic encephalopathy with lactulose. Australian Annals of Medicine, 18, 117–123.Google Scholar
  30. Martinez, A. (1968). Electron microscopy in human hepatic encephalopathy. Acta Neuropathologica, 11, 82–86.PubMedCrossRefGoogle Scholar
  31. McClain, C., Potter, T., Kromhout, J., and Zieve, L. (1984). The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy. Journal of Clinical Gastroenterology, 6, 325–329.PubMedGoogle Scholar
  32. Morgan, M., and Read, A. (1972). Antidepressants and liver disease. Gut, 13, 697–701.PubMedCrossRefGoogle Scholar
  33. Parsons-Smith, B., Summerskill, W., Dawson, A., and Sherlock, S. (1957). The electroencephalograph in liver disease. Lancet, 2, 867–871.CrossRefGoogle Scholar
  34. Read, A., Laidlow, J., and McCarthy, C. (1969). Effects of chlorpromazine in patients with hepatic disease. British Medical Journal, 3, 497–499.PubMedCrossRefGoogle Scholar
  35. Rehnstrom, S., Simert, G., Hansson, J., Johnson, G., and Vang, J. (1977). Chronic hepatic encephalopathy. A psychometrical study. Scandinavian Journal of Gastroenterology, 12, 305–311.PubMedCrossRefGoogle Scholar
  36. Resnick, R., Ishihara, A., Chalmers, T., and Schimmel, E. (1968). The Boston interhospital liver group: A controlled trial of colon bypass in chronic hepatic encephalopathy. Gastroenterology, 54, 1057–1069.PubMedGoogle Scholar
  37. Reynolds, T., Redeker, A., and Davis, P. (1958). A controlled study of the effects of L-arginine on hepatic encephalopathy. American Journal of Medicine, 25, 359–367.PubMedCrossRefGoogle Scholar
  38. Rikkers, L., Jenko, P., Rudman, D., and Freides, D. (1978). Subclinical hepatic encephalopathy: Detection, prevalence and relationship to nitrogen metabolism. Gastroenterology, 75, 462–469.PubMedGoogle Scholar
  39. Rosselli, M., Lorenzana, P., and Rosselli, A. (1985). Wilson’s Disease: A case of reversible dementia. Journal of Clinical and Experimental Neuropsychology, 7, 616 (abstract).Google Scholar
  40. Sandford, S., Sclabassi, R., Tarter, R., and Van Thiel, D. (1987). Sensory information processing in nonalcoholic cirrhosis: Visual, auditory, and somatosensory event-related potentials. Journal of the Neurological Sciences, 80, 269–276.PubMedCrossRefGoogle Scholar
  41. Schienberg, J., and Stemlieb, J. (1984). Wilson’s disease. Philadelphia: W. B. Saunders.Google Scholar
  42. Schomerus, H., Hamster, W., Blunck, H., Reinhard, U., Mayer, K., and Dole, W. (1981). Latent portasystemic encephalopathy. 1. Nature of cerebral functional defects and their effect on fitness to drive. Digestive Diseases and Sciences, 28, 622–630.CrossRefGoogle Scholar
  43. Sherlock, S., Summerskill, W., White, L., and Pheur, E. (1954). Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet, 2, 453–457.CrossRefGoogle Scholar
  44. Simmons, F., Goldstein, H., and Boyle, J. (1970). A controlled clinical trial of lactulose in hepatic encephalopathy. Gastroenterology, 59, 827–832.PubMedGoogle Scholar
  45. Smith, J., and Smith, L. (1977). WAIS functioning of cirrhotic and noncirrhotic alcoholics. Journal of Clinical Psychology, 33, 309–313.PubMedCrossRefGoogle Scholar
  46. Summerskill, W., Davidson, E., Sherlock, S., and Steiner, R. (1956). The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation. Quarterly Journal of Medicine, 25, 245–266.PubMedGoogle Scholar
  47. Tarter, R., and Edwards, K. (1985). Neuropsychology of alcoholism: In R. Tarter and D. Van Thiel (Eds.), Alcohol and the brain: Chronic effects (pp. 217–242 ). New York: Plenum Press.Google Scholar
  48. Tarter, R., Hegedus, A., Van Thiel, D., Schade, R., Cavaler, J., and Starzl, T. (1984). Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology, 86, 1421–1427.PubMedGoogle Scholar
  49. Tarter, R., Van Thiel, D., Hegedus, A., Schade, R., Cavaler, J., and Starzl, T. (1984). Liver transplantation: Long-term neuropsychiatric status. The Journal of Laboratory and Clinical Medicine, 103, 776–782.PubMedGoogle Scholar
  50. Tarter, R., Hegedus, A., Van Thiel, D., Cavaler, J., and Schade, R. (1986). Hepatic dysfunction and neuropsychological test performance in alcoholics with cirrhosis. Journal of Studies on Alcohol, 47, 74–77.PubMedGoogle Scholar
  51. Tarter, R., Hays, A., Sandford, S., Bernthal, P., and Van Thiel, D. (1986). Cerebral morphologic status is predicted by liver injury severity in patients with nonalcoholic cirrhosis. Lancet, 2, 893–895.PubMedCrossRefGoogle Scholar
  52. Tarter, R., Hegedus, A., Van Thiel, D., Edwards, N., and Schade, R. (1987). Neurobehavioral correlates of cholestatic and hepatocellular disease: Differentiation according to disease specific characteristics and severity of the identified cerebral dysfunction. International Journal of Neuroscience, 32, 901–910.PubMedCrossRefGoogle Scholar
  53. Tarter, R., Sclabassi, R., Sandford, S., Hays, A., Carra, J., and Van Thiel, D. (1987). Relationship between hepatic injury status and event related potentials. Clinical Electroencephalography, 18, 15–19.PubMedGoogle Scholar
  54. Tarter, R., Switala, J., Carra, J., Edwards, N., and Van Thiel, D. (1987). Neuropsychologic impairment in patients with Wilson’s Disease who do not exhibit overt encephalopathy. International Journal of Neuroscience.Google Scholar
  55. Tarter, R., Hays, A., Switala, J., and Van Thiel, D. (1987). The influence of Sjogren’s Syndrome on the manifest neuropsychiatric disturbances concomitant to primary hiliary cirrhosis. Unpublished manuscript.Google Scholar
  56. Victor, M., Adams, R., and Cole, M. (1965). The acquired non-Wilsonian type of chronic hepatocerebral degeneration. Medicine, 44, 345–396.PubMedCrossRefGoogle Scholar
  57. Yang, S., and Chu, Y. (1985). Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology, 89, 625–630.PubMedGoogle Scholar
  58. Zeegen, R., Drinkwater, J., and Dawson, A. (1970). Method for measuring cerebral dysfunction in patients with liver disease. British Medical Journal, 2, 633–636.PubMedCrossRefGoogle Scholar
  59. Zeneroli, M., Pinelli, G., Gollini, G., Penna, A., Messori, E., Zani, G., and Ventura, E. (1984). Visual evoked potentials: A diagnostic tool for the assessment of hepatic encephalopathy. Gut, 25, 291–299.PubMedCrossRefGoogle Scholar
  60. Zieve, L. (1979). Hepatic encephalopathy: Summary of present knowledge with an elaboration on recent developments. In H. Popper and F. Schaffner (Eds.), Progress in liver diseases (pp. 88–104 ). New York: Grune and Stratton.Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Ralph E. Tarter
    • 1
  • Kathleen L. Edwards
    • 1
  • David H. Van Thiel
    • 2
  1. 1.Department of PsychiatryUniversity of Pittsburgh School of Medicine, and Western Psychiatric Institute and ClinicPittsburghUSA
  2. 2.Department of GastroenterologyUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations